The European Haemophilia Consortium is transforming its European Inhibitor Network into the European Rare & Inhibitor Network (ERIN). With this transformation, we will seek to address the needs of people living with very rare bleeding disorders, as well as to improve their treatment and care and increase their quality of life.
Access to Treatment and Care
Ensuring patients’ access to optimal treatment and comprehensive care is the cornerstone of the EHC’s mission.
Treatment and Care
Access to treatment and care
Access to healthcare is a basic human right and one of the fundamental principles of European health systems, together with safety, quality, and equity. Access to healthcare is recognised as a right enshrined in Article 35 of the Charter of Fundamental Rights.
Health Economics Course
A unique online course, created to develop an understanding of the economics of bleeding disorders treatment in Europe and help the EHC community to better advocate for their treatment of choice.
This course covers the main concepts of health economics and evidence-based medicine, the health technology assessment (HTA) process, cost-effectiveness analysis, payment models and more. All through the application to and focus on the bleeding disorders.
Registration for this course
The registration is now closed. Please stay tuned for the 2025 edition
Open Surveys
Mapping the needs of people living with very rare bleeding disordersin NMOs Survey of European Haemophilia Consortium for individuals:
With this survey we would like to reach out directly to individuals living with (ultra-)rare bleeding disorders (if necessary, through their caregivers) to see what their challenges and needs are in order to better understand what support we can offer.
Please help us by answering this short survey. Thank you!